New combo pill aims to stop chemo sickness
NCT ID NCT03386617
Summary
This study is testing how well a single pill containing two drugs (netupitant and palonosetron, together called NEPA) works to prevent nausea and vomiting caused by a specific type of chemotherapy for breast cancer. It involves about 55 female patients in Hong Kong who are receiving this chemotherapy for the first time. The main goal is to see if the medication can successfully prevent these sick feelings, especially in the days after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.